Doctors Recommend A New Drug For The Prevention Of HIV Infection – Part 1 of 3
Doctors Recommend A New Drug For The Prevention Of HIV Infection. Should common people in danger of contracting HIV because they have risky sex clasp a pill to prevent infection, or will the medication encourage them to take even more sexual risks? After years of debate on this question, a new international study suggests the medication doesn’t lead man to stop using condoms or have more sex with more people. The research isn’t definitive, and it hasn’t changed the mind of every expert. But one of the study’s co-authors said the findings support the drug’s use as a velocity to prevent infection with HIV, the virus that causes AIDS.
And “People may have more partners or stop using condoms, but as well as we can tell, it’s not because of taking the drug to prevent HIV infection ,” said study co-author Dr Robert Grant, a older investigator with the Gladstone Institute of Virology and Immunology in San Francisco. The medication in question is called Truvada, which combines the drugs emtricitabine and tenofovir. It’s normally in use to treat people who are infected with HIV, but research – in gay and bisexual men and in straight couples with one infected partner – have shown that it can lower the risk of infection in public who become exposed to the virus through sex.
However, it does not eliminate the risk of infection. The US Food and Drug Administration approved the drug for prevention purposes in 2012. Few people seem to be taking it for check purposes, however. Its manufacturer, Gilead, has disclosed that about 1700 people are taking the drug for that reason in the United States. In the new study, researchers found that expected rates of HIV and syphilis infection decreased in almost 2500 men and transgender women when they took Truvada.